NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
3.300
+0.140 (4.43%)
At close: Sep 29, 2026, 4:00 PM EDT
3.316
+0.016 (0.49%)
Pre-market: Sep 30, 2026, 5:01 AM EDT
NeOnc Technologies Holdings Employees
NeOnc Technologies Holdings had 5 employees as of December 31, 2025. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change
-3
Growth
-37.50%
Revenue / Employee
$7,998
Profits / Employee
-$9,440,000
Market Cap
82.03M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Oncolytics Biotech | 29 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
| Cognition Therapeutics | 14 |
| Atara Biotherapeutics | 10 |
NTHI News
- 20 hours ago - NeOnc Technologies announces brain cancer pipeline advances - TheFly
- 20 hours ago - NeOnc's Powerful Brain Cancer Pipeline Advances - GlobeNewsWire
- 1 day ago - Powerful NeOnc Brain Cancer Pipeline Advances - GlobeNewsWire
- 1 day ago - NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212 - GlobeNewsWire
- 5 days ago - NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst - GlobeNewsWire
- 6 days ago - NeOnc Technologies initiated with a Buy at Roth Capital - TheFly
- 7 days ago - NeOnc's Delivery may Finally Change the Equation for Brain Cancer's Next Frontier - GlobeNewsWire
- 8 days ago - NeOnc Charting New Nasal Route to Treating Brain Cancer - GlobeNewsWire